Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$4.59 - $18.74 $128,781 - $525,788
-28,057 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$3.93 - $5.5 $3,890 - $5,445
990 Added 3.66%
28,057 $134,000
Q2 2020

Aug 14, 2020

BUY
$3.0 - $5.52 $18,078 - $33,263
6,026 Added 28.64%
27,067 $124,000
Q1 2020

May 15, 2020

BUY
$2.54 - $4.75 $53,444 - $99,944
21,041 New
21,041 $67,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $509M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.